UT Health San Antonio 4th Annual Cardio Renal Connection 2021

A practical, case-based meeting at the intersection of cardiovascular and kidney disease. Faculty translate current evidence into coordinated care pathways that improve outcomes for patients with CKD, HF, diabetes, and hypertension across inpatient and ambulatory settings.
What You Will Learn

Integrated risk stratification for CKD, ASCVD, and heart failure—including how to stage, phenotype, and prioritize therapy

Guideline-aligned use of SGLT2 inhibitors, GLP-1 RAs, MRAs (finerenone), RAAS blockade, diuretics, and lipid-lowering therapy

Blood pressure in CKD/HF: targets, combinations, hyperkalemia mitigation, and resistant HTN algorithms

HF in CKD: congestion assessment, diuretic strategies, GDMT initiation/titration with renal monitoring

Diabetes and CKD: glycemic goals, medication selection by eGFR, hypoglycemia prevention, and kidney-protective pathways

AKI and contrast strategies in cardiac patients; peri-procedural kidney protection

Anemia, bone-mineral disease, and metabolic complications that impact CV risk

Team-based coordination: cardiology–nephrology co-management, pharmacy support, and patient education tools

Event Details

Format: Live lectures with case panels, multidisciplinary debates, and concise take-home checklists

Structure: Thematic blocks (risk/prevention, therapeutics, HF/CKD, diabetes/CKD, complications, systems of care) designed for next-day implementation

Who Should AttendCardiologists, nephrologists, hospitalists, primary-care clinicians, endocrinologists, advanced practice providers, pharmacists, nurses, and trainees caring for patients with overlapping cardio-renal-metabolic disease.
Why Attend

Convert complex, cross-specialty guidance into simple, shared workflows

Improve safety and outcomes by aligning medications, labs, and follow-up across teams

Bring back algorithms, order-set prompts, and counseling scripts that work in busy clinics and wards

 
+ Topics:
Schedule.pdf